IHS Chemical Week

Regions :: North America :: U.S.

Merck to License Codexis Technology

1:44 PM MDT | April 18, 2007 | Chemical Week Editorial Staff

Codexis (Redwood City, CA) says it has entered into an agreement with Merck, under which Merck will gain non-exclusive access to Codexis’s biocatalysts for in-house screening. Financial details were not disclosed. Codexis says it has developed sets of diagnostic enzymes optimized for pharmaceutical manufacturing that partners can use internally to screen for reactivity in desired process...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa